- Home
- VNDA vs GLO Comparison
VNDA vs GLO Comparison
Compare VNDA & GLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- GLO
- Stock Information
- Founded
- VNDA 2002
- GLO 2006
- Country
- VNDA United States
- GLO United States
- Employees
- VNDA N/A
- GLO N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- GLO Finance/Investors Services
- Sector
- VNDA Health Care
- GLO Finance
- Exchange
- VNDA Nasdaq
- GLO Nasdaq
- Market Cap
- VNDA 249.4M
- GLO 241.2M
- IPO Year
- VNDA 2006
- GLO N/A
- Fundamental
- Price
- VNDA $4.51
- GLO $5.68
- Analyst Decision
- VNDA Strong Buy
- GLO
- Analyst Count
- VNDA 2
- GLO 0
- Target Price
- VNDA $16.50
- GLO N/A
- AVG Volume (30 Days)
- VNDA 404.6K
- GLO 170.5K
- Earning Date
- VNDA 11-05-2025
- GLO 01-01-0001
- Dividend Yield
- VNDA N/A
- GLO 11.38%
- EPS Growth
- VNDA N/A
- GLO N/A
- EPS
- VNDA N/A
- GLO N/A
- Revenue
- VNDA $203,467,000.00
- GLO N/A
- Revenue This Year
- VNDA $15.45
- GLO N/A
- Revenue Next Year
- VNDA $37.82
- GLO N/A
- P/E Ratio
- VNDA N/A
- GLO N/A
- Revenue Growth
- VNDA 11.78
- GLO N/A
- 52 Week Low
- VNDA $3.81
- GLO $4.08
- 52 Week High
- VNDA $5.55
- GLO $5.18
- Technical
- Relative Strength Index (RSI)
- VNDA 46.90
- GLO 67.05
- Support Level
- VNDA $4.54
- GLO $5.63
- Resistance Level
- VNDA $4.64
- GLO $5.60
- Average True Range (ATR)
- VNDA 0.15
- GLO 0.05
- MACD
- VNDA -0.01
- GLO 0.01
- Stochastic Oscillator
- VNDA 8.89
- GLO 88.10
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About GLO Clough Global Opportunities Fund
Clough Global Opportunities Fund is a closed-end management investment company based in the United States. Its investment objective is to provide a high level of total return by investing in equity securities of companies of any market capitalization and equity-related securities, including equity swaps and call options, as well as fixed-income securities, including both corporate and sovereign debt, in both U.S. and non-U.S. markets.